Drug intelligence / Profile preview

autologous adipose-derived mesenchymal stem cells (Andalusian Initiative for Advanced Therapies)

Development stage: Unknown
Lead developer: Red Andaluza de Terapias Avanzadas
Modality: Stem Cell Therapies → Cell Therapies
Administration: Intravenous

Overview

This investigational cell therapy consists of autologous adipose-derived mesenchymal stem cells (AdMSC) developed by the Andalusian Initiative for Advanced Therapies through the Fundación Pública Andaluza Progreso y Salud. Specifically designed for the treatment of amyotrophic lateral sclerosis (ALS), the therapy involves the extraction of mesenchymal stem cells from a patient's own adipose tissue, which are then processed into a suspension for intravenous administration. The therapeutic approach aims to leverage the innate ability of MSCs to modulate the immune system and provide neuroprotective effects, potentially slowing the progression of motor neuron degeneration. It has been evaluated in a multicenter, randomized, placebo-controlled Phase I/II clinical trial (EudraCT 2011-006254-85) to assess safety and efficacy across multiple dosing levels in patients with moderate to severe ALS.

Other names: mesenchymal stem cells-Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud-amyotrophic lateral sclerosisAdMSCAutologous adipose-derived mesenchymal stem cellsAutologous MSC

Beyond the preview

Go deeper on autologous adipose-derived mesenchymal stem cells (Andalusian Initiative for Advanced Therapies).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous adipose-derived mesenchymal stem cells (Andalusian Initiative for Advanced Therapies).

Explore the full profile